KOL Insights on the ADA Scientific Session Featuring Matthias H. Tschöp, MD

As a part of HealthDay’s conference coverage, Dr. Matthias Tschöp joins us to share exciting research on the drug Tirzepatide discussed at this year’s American Diabetes Association’s Scientific Session.